Western Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $216K | Buy |
3,098
+213
| +7% | +$14.9K | 0.01% | 666 |
|
|
2025
Q1 | $212K | Sell |
2,885
-244
| -8% | -$17.9K | 0.01% | 634 |
|
|
2024
Q4 | $205K | Sell |
3,129
-356
| -10% | -$23.3K | 0.01% | 636 |
|
|
2024
Q3 | $272K | Buy |
3,485
+70
| +2% | +$5.45K | 0.02% | 631 |
|
|
2024
Q2 | $266K | Sell |
3,415
-94
| -3% | -$7.33K | 0.02% | 532 |
|
|
2024
Q1 | $238K | Buy |
3,509
+60
| +2% | +$4.07K | 0.02% | 577 |
|
|
2023
Q4 | $232K | Buy |
3,449
+30
| +0.9% | +$2.02K | 0.02% | 620 |
|
|
2023
Q3 | $232K | Buy |
3,419
+27
| +0.8% | +$1.83K | 0.02% | 571 |
|
|
2023
Q2 | $243K | Sell |
3,392
-36
| -1% | -$2.58K | 0.02% | 560 |
|
|
2023
Q1 | $238K | Buy |
3,428
+238
| +7% | +$16.5K | 0.02% | 562 |
|
|
2022
Q4 | $216K | Sell |
3,190
-7,004
| -69% | -$475K | 0.02% | 552 |
|
|
2022
Q3 | $559K | Buy |
10,194
+2,436
| +31% | +$134K | 0.03% | 444 |
|
|
2022
Q2 | $512K | Sell |
7,758
-398
| -5% | -$26.3K | 0.03% | 469 |
|
|
2022
Q1 | $541K | Buy |
8,156
+2,322
| +40% | +$154K | 0.03% | 507 |
|
|
2021
Q4 | $340K | Buy |
+5,834
| New | +$340K | 0.03% | 429 |
|